On efficacy against the Omicron variant, Bharat Biotech said Covaxin was developed against the original Wuhan variant and has worked against other variants, and the company would continue to research on new variants. Vaccine maker Bharat Biotech on Monday said it has commenced exports of its Covid-19 vaccine Covaxin. The company said the first set … Read more
It also said that the calf serum is particularly beneficial in order to facilitate growth of a difficult to grow disease-causing virus or micro-organisms. In the wake of information circulating on the internet about the possible use of newborn calf in Covaxin, the central government has clarified that Covaxin vaccine does not contain the serum … Read more
Consequently, the Hyderabad-based pharma company had also released phase-3 interim clinical data that had shown vaccine efficacy rate of 78 percent in April this year. The third phase clinical data of Coronavirus vaccine developed by Hyderabad-based Bharat Biotech is going to be released in a week’s time, VK Paul who is the head of the … Read more
These countries are highly satisfied with the safe, inactivated vaccine technology and robust data package for safety and immunogenicity.” The much-awaited result from the phase 3 clinical trials of Covaxin, the vaccine that has been granted emergency use authorization under a trial mode, is finally out and the news seems encouraging. What is however awaited … Read more